CDDF & EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development

EORTC and the Cancer Drug Development Forum (CDDF) will jointly organise a two‑day multi‑stakeholder workshop focused on Health Technology Assessment (HTA) in cancer drug development. The workshop will address key challenges and opportunities related to evidence generation, assessment methodologies, and decision‑making processes across the cancer care continuum.

The event will convene experts from academia, regulatory bodies, HTA agencies, patient organisations, and other stakeholders involved in oncology research and policy.

Event information

Event page: https://cddf.org/events/upcoming-events/cddf-workshop-october-2026/
Registration: https://cddf.org/events/upcoming-events/cddf-workshop-october-2026/registration/

Registration fees

Registration is free of charge for the following participant categories:

• Academics
• Representatives from foundations, non‑profit organisations, or charities
• Regulators (national regulatory agencies, HTA bodies, EMA, FDA)
• Students and nurses
• Patient advocates

Dates: 5 – 6 October 2026
Location: hybrid, Brussels (BE)